Posted by vanvog on April 19, 2013, at 21:46:57
In reply to Re: Parnate Brands/Manufacturers, posted by vanvog on April 19, 2013, at 17:43:11
I found an article on Rising Pharmaceuticals from November 2, 2012:
------------------------------------------
ACETO Subsidiary, Rising Pharmaceuticals, Announces the Signing of Their First Agreement to Market an Authorized Generic Drug (Parnate(R) Product) With Covis Pharma S.a.r.l.PORT WASHINGTON, N.Y., Nov. 2, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Intermediates and Performance Chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, has signed a definitive agreement to market an authorized generic of the 10mg strength of Tranylcypromine Sulfate Tablets, an FDA approved authorized generic version of Covis Pharma's Parnate® product. According to IMS Health data, U.S. market sales for Tranylcypromine Sulfate Tablets, which is used for the treatment of depression, were approximately $8 million for the twelve months ended June 2012.
------------------------------------------The last sentence contains a very interesting piece of information because a) $8 million is like "nothing" in the world of (big) pharma and b) the number can give you a good estimation of current Parnate users in the US. Something like 3000 to 5000 CONTINUOUS Parnate patients? That seems a surprisingly low number but that might be just for the generic Tranylcypromine Sulfate, brand name Parnate sales are probably much higher, unfortunately I couldn't find any mention of Parnate in GSK's old Annual Reports or any data on the Parnate (brand-name) market. I found some reliable info from 2004 saying that in Germany (population 82 million) there were ~6800 Parnate patients that year. I remember reading something about 30000 Parnate users in the world but I really don't know where this number came from or how accurate it is.
Another thought, I think there were many more manufacturers of Tranylcypromine some years ago but in a series of acquisitions the market for Parnate consolidated leaving GSK and just one generic manufacturer (in the US), also in many countries no generic Parnate is available, probably the market there is relatively small as it is leaving no place for profitable generic niche. In some developed countries like Japan and some European countries there is apparently NO Parnate brand-name or generic available at all, go figure.
poster:vanvog
thread:1042344
URL: http://www.dr-bob.org/babble/20130408/msgs/1042375.html